Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

State legislators are moving to advance US Health and Human Services Secretary Robert F. Kennedy Jr.’s push for greater ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

Kim V. Narry, director of the Center for RNA Research of the Institute for Basic Science and chair professor at the ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.

This renewed interest has largely been attributed to the success of messenger RNA (mRNA) vaccines employed during the COVID-19 pandemic. These vaccines helped beat back the virus and showed that mRNA ...